Asenapine: Side Effects, Uses & Monitoring
Facts extracted from current FDA product labeling for Asenapine. Educational only — not medical advice.
Labeled uses
Asenapine sublingual tablets are indicated for: Schizophrenia in adults [see Clinical Studies (14.1) ] Bipolar I disorder [see Clinical Studies (14.2) ] Acute monotherapy of manic or mixed episodes, in adults and pediatric patients 10 to 17 years of age Adjunctive treatment to lithium or valproate in adults Maintenance monotherapy treatment in adults
Source: FDA labeling via NIH DailyMed (set 4c7a1b17…). Not affiliated with FDA or NIH.
Medical disclaimer: Always consult a qualified healthcare professional about any medication.